Connect with us
[the_ad id="89560"]

Business

Pharma, WHO team up to create permanent ‘pandemic’ market for mandated, experimental vaccines

Published

14 minute read

From LifeSiteNews

By Brenda Baletti, Ph.D., The Defender

Unlimited Hangout journalist Max Jones details how Big Pharma is using the WHO to restructure the drug market, so inadequately tested vaccines and other drugs will face minimal regulation and entire populations can be compelled to take them each time the WHO declares another global pandemic.

Big Pharma and its key investors are rolling out a new strategy — “the full takeover of the public sector, specifically the World Health Organization (WHO), and the regulatory system that now holds the entire market hostage” — according to a new investigative report by Unlimited Hangout’s Max Jones.

What’s behind the new strategy? The pharmaceutical industry is facing a “patent cliff” by 2030, as many of its blockbuster drugs are set to lose their patent protection, placing $180 billion in sales at risk and threatening to topple the industry.

According to Jones, for years, when patents expired on profitable drugs, pharmaceutical giants deployed a “mergers and acquisitions” strategy, buying up smaller drug companies to add to their product portfolios.

As a result, the industry is now dominated by a handful of companies, conventional chemical drugs exist for most health issues, and the regulatory process for new ones has become onerous.

Big Pharma has now pivoted to acquiring biotech and biologic companies, whose products are “more complex, unpredictable and difficult and expensive to make,” than chemical-based medicine, Jones wrote.

Conventional drugs are chemically synthesized and have a known structure according to the U.S. Food and Drug Administration (FDA). Biologics come from living humans, animal or microorganism cells, and are technologically altered to target particular proteins or cells in the immune system. The FDA calls biologics “complex mixtures that are not easily identified or characterized.”

As a drug class, biologics offer an appealing solution to the patent cliff problem, because they can’t be easily replicated like generic versions of conventional drugs.

However, Jones wrote, the serious safety issues associated with biologics — the high risk of serious adverse events associated with the COVID-19 vaccine, for example — make it difficult for drugmakers to find commercial success in a conventional regulatory environment.

“Luckily for Big Pharma,” Jones wrote, the WHO and its private backers “are pursuing an unprecedented legal process that would cement loopholes that could solve these significant market challenges of at least some biotechnologies.”

Such loopholes made Pfizer and Moderna’s COVID-19 mRNA vaccines — the paradigmatic example of this new strategy — Big Pharma’s highest-selling annual market success ever.

Distribution of the COVID-19 vaccines to approximately 70% of people globally was possible only because of the “fast-tracked, deregulated development and mandated consumption of the experimental drugs,” Jones wrote.

The industry hopes to replicate that model with other drugs. And it has already begun — last month the Biomedical Advanced Research and Development Authority, or BARDA, gave Moderna $176 million to develop an mRNA bird flu vaccine.

Stakeholders behind the WHO have turned it into an arm of Big Pharma

According to Jones, the process of rapidly developed and mandated experimental drugs was first adopted by the U.S. military for bioweapons threats. Now, it is being internationally legitimized by the WHO through the agency’s revisions to the International Health Regulations (IHR) and its continued attempt to push its pandemic treaty.

The amendments were watered down and the treaty was partially thwarted at the last meeting of the World Health Assembly, which ended on June 1. However, the powers added to the amendments and the language in the treaty WHO and its backers are still hoping to advance next year show the type of biotech pandemic market Big Pharma has in the works.

According to Jones, this market:

Will not be one that depends on the free will of consumers to opt in and out of products — but instead relies on tactics of forced consumption and manipulation of regulatory paradigms.

At the forefront of this push are the WHO’s public-private-partners/private stakeholders, who directly shape and benefit from this policy. Their influence has, in effect, turned the WHO into an arm of Big Pharma, one so powerful that it already demonstrated its ability to morph the entire international regulatory process for the benefit of the pharmaceutical industry during the COVID-19 pandemic.

These stakeholders can wield this power in part because the WHO receives 80% of its funding from private stakeholders.

Those stakeholders include private-sector giants like Bill Gates, his public-private partnership organizations like the Coalition for Epidemic Preparedness Innovations (CEPI) and public-sector bureaucrats, such as Dr. Anthony Fauci and Rick Bright, Ph.D., of BARDA and the Rockefeller Foundation, who have been working for years to create a new system that would speed up vaccine production.

During the COVID-19 pandemic period, even states that lacked legal structures to provide emergency authorization for new drugs created them, using the WHO’s Emergency Use Listing Procedure (EUL) as justification, and aided by the WHO’s COVAX vaccine distribution system. COVAX was co-led by the WHO, Gavi, CEPI and Unicef, which are all backed by Gates.

The goal now, Jones wrote, is to institutionalize the procedures that were put in place globally for COVID-19 to pave the way for a new pandemic market.

The One Health agenda, which requires “full-scale surveillance of the human-animal environment,” both before and during pandemics, is central to this plan, he wrote.

The four pillars of the emerging pandemic market

There are four pillars to the plan for securing this market. The pillars are embodied in the WHO’s recently passed IHR amendments and the proposed pandemic treaty.

1. Biosurveillance of “pathogens with pandemic potential”: The WHO is calling on member states to create infrastructure to conduct biosurveillance on entire populations.

WHO private stakeholders, like the Wellcome Trust and the Bill & Melinda Gates Foundation, have been funding such initiatives for years and continue to be at the forefront of similar initiatives today, Jones wrote.

2. Rapid sharing of data and research: Under the IHR amendments, the WHO’s director-general must provide support for member states’ research and development. In the pending treaty, that would include helping them rapidly share data during a pandemic.

Such sharing should help coordinate global pandemic responses and also “pandemic prevention.” That means building a globally coordinated effort to research and share data on diseases that don’t currently pose a public health threat but are allegedly “likely to cause epidemics in the future.”

The WHO’s announcement last week that it is facilitating data-sharing for a new mRNA bird flu vaccine from Argentina is one example.

Experts have raised concerns that incentivizing such “preventive R&D” could incentivize risky gain-of-function research, Jones wrote.

Jones also noted that it is “highly likely” that the same global organizations that partner with the WHO and are funded by its largest private donors will be the ones doing this research and development on vaccines for “future pathogens with pandemic potential” — and also the ones profiting from it.

3. New regulatory pathways: The WHO is developing new regulatory pathways for unapproved medical products to get to market during pandemic emergencies. The IHR amendments are vague on this, Jones wrote, but the proposed language of the treaty aims to speed up emergency authorizations of WHO-recommended investigational “relevant health products.”

The proposed treaty also seeks to compel member countries to take steps to ensure they have the “legal, administrative and financial frameworks in place to support emergency regulatory authorizations for the effective and timely approval of pandemic-related health products during a pandemic.”

4. Global mandates of unapproved products: The final key element in the Big Pharma-WHO plan to pave the way for a new pandemic market is shoring up the global capacity to mandate unapproved medical products.

According to Jones, in July 2023, the WHO adopted the European Union’s (EU) digital COVID-19 passport system, or the “immunity pass” which recorded people’s vaccination records, negative test results or records of previous infections.

“While a digital vaccine passport does not function as a hard mandate in which every citizen of a given population is forced to take a vaccine, it acts as a conditional mandate — one which offers the illusion of choice, but — in reality — restricts the civil liberties of those who do not comply,” Jones wrote.

The 2005 version of the IHR allowed for travel-based mandates that required proof of vaccination to enter countries when there was a public health risk. The new IHR, Jones wrote, expands on this by detailing the kinds of technology that can be used to check such information during future pandemics.

The WHO also is developing its Global Digital Health Certification Network, which expands the EU digital passport system to a global scale. It will digitize vaccination records and health records and will be “interoperable” with existing networks.

While interoperability makes it possible for decentralized data to be shared globally, Jones wrote, “The UN is seeking to impose digital identification as a ‘human right,’ or rather as a condition for accessing other human rights, for the entire global citizenry by 2030, as established in its Sustainable Development Goal 16.9.”

The initiative seeks to provide people with a “trusted, verifiable way” to prove who they are in the physical world and online.

Jones wrote:

Verification systems of this size will place the right of citizens to do basic activities — like traveling, eating at a restaurant or working their job — in the hands of governments and potentially employers.

The rights of civilians will be conditional, dictated by data stored in a massive digital hub that is global in its sharing abilities. Not only will domestic governments have access to the health information of their own citizens under this system, but an entire global bureaucracy will as well.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

Business

B.C. Credit Downgrade Signals Deepening Fiscal Trouble

Published on

The Opposition with Dan Knight   Dan Knight

Spending is up, debt is exploding, and taxpayers are footing the bill—how David Eby’s reckless economics just pushed British Columbia one step closer to the brink.

So here’s something they’re not going to explain on CBC—British Columbia just got slapped with yet another credit downgrade. Actually, two. On April 2nd, both S&P Global and Moody’s—two of the most powerful financial watchdogs on the planet—downgraded B.C.’s credit rating. And not by accident. This wasn’t a glitch in the system or some market hiccup. This was a direct consequence of political recklessness.

Let’s talk numbers. S&P cut B.C.’s rating from ‘AA-’ to ‘A+’. Moody’s dropped it from ‘aa1’ to ‘aa2’. That’s the fourth downgrade in four years. Four. This is a province that used to hold AAA status—the financial gold standard. That means British Columbia was once considered one of the most fiscally stable jurisdictions not just in Canada, but globally. Not anymore.

Even more alarming? S&P didn’t just hit their long-term rating—they downgraded the short-term rating too, from ‘A-1+’ to ‘A-1’. Why? Because even in the short term, B.C. is starting to look like a risk. A liquidity risk. That means the money might not be there when it’s needed. That’s a red flag for anyone with a calculator and a memory longer than five minutes.

This is not some vague bureaucratic move. This is a direct indictment of the NDP’s economic policies in British Columbia. This is what happens when you treat taxpayers like an ATM machine and the economy like a social experiment. And now, international financial institutions are officially saying what a lot of people have been screaming for years: B.C. is in serious fiscal trouble.

Causes: Spending, Deficits, and Revenue Pressure

The core driver behind the downgrades is the ballooning of operating and capital deficits, coupled with aggressive government spending. According to B.C.’s 2025 budget, unveiled by Finance Minister Brenda Bailey on March 4, the provincial deficit is projected to hit $10.9 billion in 2025–26—up from $9.1 billion the previous year. Moody’s projects an even higher shortfall of $14.3 billion, raising red flags about B.C.’s ability to fund programs without unsustainable borrowing.

S&P cited the impact of reduced immigration levels and ongoing trade uncertainty as key headwinds, limiting economic growth and shrinking the province’s revenue base. Moody’s pointed to persistent budgetary gaps and limited progress on deficit reduction, highlighting the growing gap between revenue and expenditure.

Additionally, spending growth has significantly outpaced both population and inflation. Data from the Fraser Institute shows that between 2019/20 and 2024/25, program spending increased by 51.6%, whereas only 29.2% was needed to keep pace with demographic and price trends. This excess has pushed real per-capita expenditures to historic highs, without a corresponding rise in revenue.

Opposition Blames NDP Mismanagement for Downgrade

But what does that actually mean for real people—not bureaucrats, not lobbyists—but the mom on a fixed income buying groceries? So I reached out to John Rustad, leader of the Official Opposition in B.C., to ask exactly that.

“Two downgrades! Absolute disaster,” he told me. “Under David Eby, we’ve gone from a AAA status to a single A with a negative outlook. This government’s reckless spending and irresponsible management will have a devastating effect—not just today, but for generations to come.”

He’s not exaggerating. According to Rustad, by the end of this fiscal period, B.C.’s debt will have nearly tripled since the NDP took power. Let that sink in—tripled. And no, this isn’t just some abstract macroeconomic trend. This hits you. Directly.

Rustad laid it out. These downgrades mean higher borrowing costs for the province. That’s code for more taxpayer money getting funneled into interest payments instead of hospitals, schools, or—God forbid—tax relief.

“By the end of this fiscal plan, even before the downgrade and before the loss of billions in carbon tax revenue, interest payments were projected to hit $7 billion annually,” Rustad said. “That’s about 30% of personal income tax revenue—just to pay the interest.”

That’s money you send to Victoria every month—just lighting it on fire.

And with the downgrade? Expect to pay another $1 billion more in interest. That’s around $200 per person, per year. Not for roads. Not for services. Just to keep the debt monster fed.

Meanwhile, Premier David Eby—well, he’s had months to plan for replacing the carbon tax, and guess what? Still no plan. Rustad told me he expected Eby to raise industrial taxes to make up the difference, but even that hasn’t happened yet. For now, the hole is just growing—a $2 billion loss in carbon tax revenue on top of an $11 billion deficit.

So What Does This Mean for the Average Mom?

In response to a direct question about what this credit downgrade means for a mother living on a fixed income, Opposition Leader John Rustad laid out the long-term consequences in no uncertain terms:

“The average person will not notice this immediately. But what it does mean is higher borrowing costs, So with the massive deficit and debt, more money will need to be spent on interest payments. By the end of this fiscal, before loss of billions in carbon tax revenue and before the debt downgrades, interest payments would increase to about $7 billion by the end of the fiscal plan. To put that in perspective, that would be the equivalent of 30% or more of personal income taxes just to pay interest.”

He continued:

“The debt downgrades mean the province will have to pay more in interest—likely 1/4 to 1/2% more. On $220+ billion, that could mean $1 billion more in interest. That could be about $200 per man, woman and child annually in more interest by 2027.”

And with no plan to rein in spending, Rustad issued a stark warning:

“The compounding problem is: will this mean service cuts, more taxes, or yet more debt to be paid by our children?”

Final Thoughts

So here’s a question no one on CBC is going to ask: What actually happens when a progressive government can’t manage a budget? I’ll tell you. You get poorer. That’s what happens. You, the person who gets up every day and works a real job, pays the price while the people in charge keep living large off your labour.

Let’s walk through it. First, you pay provincial income tax—a tax just for working. Imagine that. You go out, earn a living, and the government takes a cut just because you dared to be productive. Then there’s the PST—you buy something, anything, and you get taxed again. Why? Because you had the audacity to participate in the economy.

And then there’s the carbon tax, the holy grail of progressive grifts. This wasn’t about saving the planet—it was about propping up the very same government that couldn’t manage a piggy bank, let alone a provincial budget. That tax was floating David Eby’s spending addiction. Now it’s gone, and surprise—there’s no plan to replace it. Just more debt, more interest, and more economic chaos.

But wait—here’s the part that really insults your intelligence. After taxing you into the ground, they turn around and say, “Don’t worry, we’ll give you a rebate.” A rebate? You mean you’re going to give me back a tiny fraction of the money you stole from me and act like you’re doing me a favour? Please. That’s not generosity—it’s gaslighting. It’s economic abuse wrapped in a government cheque.

And that’s why I keep saying it: fiscal responsibility matters. Because I’d rather have that money in my wallet, feeding my kids, paying my bills, building my future—than watching David Eby burn it on pet projects, political theatre, and bloated bureaucracy.

But here’s the thing—there is hope. It’s not all doom and despair. In the last election, something incredible happened. The BC Conservatives, a party written off by the elites and ignored by the media, pulled off a political miracle. They surged from obscurity to contention—why? Because regular people are waking up. Because the voters who pay the bills, raise the kids, and still believe in common sense are done being treated like ATMs for a government that doesn’t even pretend to respect them.

And maybe—just maybe—after a little more pain, after a little more David Eby-style financial recklessness, the voters of this province will finally realize why fiscal responsibility matters. Not because it sounds good in a press release, but because without it, your future vanishes. Your freedom shrinks. And the people in charge? They just keep spending.

So next time, when the ballots are counted and the smoke clears, maybe British Columbia will finally remember who this province belongs to—not to bureaucrats, not to activists, not to the political class in Victoria—but to you.

And that day can’t come soon enough.

Subscribe to The Opposition with Dan Knight .

For the full experience, upgrade your subscription.

Continue Reading

Business

California planning to double film tax credits amid industry decline

Published on

From The Center Square

By

California legislators have unveiled a bill to follow through with the governor’s plan of more than doubling the state’s film and TV production tax credits to $750 million.

The state’s own analysis warns it’s likely the refundable production credits generate only 20 to 50 cents of state revenue for every dollar the state spends, and the increase could stoke a “race to the bottom” among the 38 states that now have such programs.

Industry insiders say the state’s high production costs are to blame for much of the exodus, and experts say the cost of housing is responsible for a significant share of the higher costs.

The bill creates a special carve-out for shooting in Los Angeles, where productions would be able to claim refundable credits for 35% of the cost of production.

California Gov. Gavin Newsom announced his proposal last year and highlighted his goal of expanding the program at an industry event last week.

“California is the entertainment capital of the world – and we’re committed to ensuring we stay that way,” said Newsom. “Fashion and film go hand in hand, helping to express characters, capture eras in time and reflect cultural movements.”

With most states now offering production credits, economic analysis suggests these programs now produce state revenue well below the cost of the credits themselves.

“A recent study from the Los Angeles County Economic Development Corporation found that each $1 of Program 2.0 credit results in $1.07 in new state and local government revenue. This finding, however, is significantly overstated due to the study’s use of implausible assumptions,” wrote the state’s analysts in a 2023 report. “Most importantly, the study assumes that no productions receiving tax credits would have filmed here in the absence of the credit.”

“This is out of line with economic research discussed above which suggests tax credits influence location decisions of only a portion of recipients,” continued the state analysis. “Two studies that better reflect this research finding suggest that each $1 of film credit results in $0.20 to $0.50 of state revenues.”

“Parks and Recreation” stars Rob Lowe and Adam Scott recently shared on Lowe’s podcast how costs are so high their show likely would have been shot in Europe instead.

“It’s cheaper to bring 100 American people to Ireland than to walk across the lot at Fox past the sound stages and do it and do it there,” said Lowe.

“Do you think if we shot ‘Parks’ right now, we would be in Budapest?” asked Scott, who now stars in “Severance.”

“100%,” replied Lowe. “All those other places are offering 40% — forty percent — and then on top of that there’s other stuff that they do, and then that’s not even talking about the union stuff. That’s just tax economics of it all.”

“It’s criminal what California and LA have let happen. It’s criminal,” continued Lowe. “Everybody should be fired.”

According to the Public Policy Institute of California, housing is the single largest expense for California households.

“Across the income spectrum, 35–44% of household expenditures go to covering rent, mortgages, utilities and home maintenance,” wrote PPIC.

The cost of housing due to supply constraints now makes it nearly impossible for creatives to get their start in LA, said M. Nolan Gray, legislative director at housing regulatory reform organization California YIMBY.

“Hollywood depends on Los Angeles being the place where anybody can show up, take a big risk, and pursue their dreams, and that only works if you have a lot of affordable apartments,” said Gray to The Center Square. “We’ve built a Los Angeles where you have to be fabulously wealthy to have stable and decent housing, and as a result a lot of folks either are not coming, or those who are coming need to paid quite a bit higher to make it worth it, and it’s destroying one of California’s most important industries.”

“Anybody who arrived in Hollywood before the 2010s, their story is always, ‘Yeah, I showed up in LA, and I lived in a really, really  dirt-cheap apartment with like $10 in my pocket.’ That just doesn’t exist anymore,” continued Gray. “Does the Walt Disney of 2025 not take the train from Kansas City to LA? Almost certainly not. If he goes anywhere, he goes to Atlanta.”

Continue Reading

Trending

X